Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Systemic reactions to inhalant immunotherapy using 1:1 target dosing.

Holland CL, Samuels KM, Baldwin JL, Greenhawt MJ.

Ann Allergy Asthma Immunol. 2014 May;112(5):453-8. doi: 10.1016/j.anai.2014.02.008.

PMID:
24631183
2.

The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.

Adamic K, Zidarn M, Bajrovic N, Erzen R, Kopac P, Music E.

Wien Klin Wochenschr. 2009;121(9-10):357-60. doi: 10.1007/s00508-009-1172-0.

PMID:
19562302
3.

Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010.

Santos N, Pereira AM, Silva R, Torres da Costa J, Plácido JL.

Allergol Immunopathol (Madr). 2015 Jan-Feb;43(1):25-31. doi: 10.1016/j.aller.2013.10.006.

PMID:
24661594
4.

Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.

Kartal O, Gulec M, Caliskaner Z, Musabak U, Sener O.

Immunopharmacol Immunotoxicol. 2015 Jun;37(3):280-6. doi: 10.3109/08923973.2015.1027918.

PMID:
25858053
5.

Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.

Serrano P, Justicia JL, Sánchez C, Cimarra M, Fernández-Távora L, Orovitg A, Moreno C, Guerra F, Alvà V.

Ann Allergy Asthma Immunol. 2009 Mar;102(3):247-52. doi: 10.1016/S1081-1206(10)60088-9.

PMID:
19354072
6.

Safety of inhalant allergen immunotherapy with mass units-standardized extracts.

Nettis E, Giordano D, Pannofino A, Ferrannini A, Tursi A.

Clin Exp Allergy. 2002 Dec;32(12):1745-9.

PMID:
12653166
7.

Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy.

Roy SR, Sigmon JR, Olivier J, Moffitt JE, Brown DA, Marshall GD.

Ann Allergy Asthma Immunol. 2007 Jul;99(1):82-6.

PMID:
17650835
8.
9.

[Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].

Wang HY, Lin XP, Hao CL, Zhang CQ, Sun BQ, Zheng JP, Chen P, Sheng JY, Wu A, Zhong NS.

Zhonghua Jie He He Hu Xi Za Zhi. 2006 Oct;29(10):679-87. Chinese.

PMID:
17129496
10.

Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey.

Bahceci Erdem S, Nacaroglu HT, Karaman S, Unsal Karkıner CS, Gunay I, Dogan D, Asilsoy S, Altınoz S, Can D.

Int J Pediatr Otorhinolaryngol. 2016 May;84:55-60. doi: 10.1016/j.ijporl.2016.02.032.

PMID:
27063754
11.

Analysis of an unusual cluster of systemic reactions to subcutaneous specific immunotherapy with respiratory allergens in one allergy center.

Scherer K, Schindler C, Arnold A, Bach S, Bircher AJ.

Int Arch Allergy Immunol. 2012;157(3):318-20. doi: 10.1159/000328753.

PMID:
22056648
12.

Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice.

Copenhaver CC, Parker A, Patch S.

Ann Allergy Asthma Immunol. 2011 Nov;107(5):441-7. doi: 10.1016/j.anai.2011.06.026.

PMID:
22018617
13.

Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparation.

Pfaar O, van Twuijver E, Hecker H, Boot JD, van Ree R, Klimek L.

Int Arch Allergy Immunol. 2013;160(4):420-4. doi: 10.1159/000343026.

PMID:
23183541
14.

Incidence and characteristics of biphasic reactions after allergen immunotherapy.

Scranton SE, Gonzalez EG, Waibel KH.

J Allergy Clin Immunol. 2009 Feb;123(2):493-8. doi: 10.1016/j.jaci.2008.10.026.

PMID:
19064282
15.

Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine.

Phillips JF, Lockey RF, Fox RW, Ledford DK, Glaum MC.

Allergy Asthma Proc. 2011 Jul-Aug;32(4):288-94. doi: 10.2500/aap.2011.32.3446.

PMID:
21781404
16.

Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience.

Ragusa FV, Passalacqua G, Gambardella R, Campanari S, Barbieri MM, Scordamaglia A, Canonica GW.

J Investig Allergol Clin Immunol. 1997 May-Jun;7(3):151-4.

PMID:
9252872
17.

Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients.

Rogala B, Markiewicz-Bendkowska IB, Brzoza Z, Glück J, Oleś E.

Rhinology. 2007 Jun;45(2):134-9.

PMID:
17708460
18.

Safety aspects of subcutaneous immunotherapy with multiple allergens--a retrospective analysis on polysensitized patients.

Barth C, Anero F, Pfaar O, Klimek L, Hörmann K, Stuck BA.

Eur Arch Otorhinolaryngol. 2010 Dec;267(12):1873-9. doi: 10.1007/s00405-010-1262-7.

PMID:
20454971
19.

Immediate adverse reactions to immunotherapy.

Can D, Demir E, Tanaç R, Gülen F, Yenigün A.

J Investig Allergol Clin Immunol. 2003;13(3):177-80.

PMID:
14635467
20.

Venom immunotherapy for preventing allergic reactions to insect stings.

Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JN.

Cochrane Database Syst Rev. 2012 Oct 17;10:CD008838. doi: 10.1002/14651858.CD008838.pub2. Review.

PMID:
23076950
Items per page

Supplemental Content

Support Center